TWD 19.4
(-9.98%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 995 Thousand TWD | 3.27% |
2022 | 252.6 Million TWD | 27.33% |
2021 | 198.38 Million TWD | -7.4% |
2020 | 214.24 Million TWD | -20.65% |
2019 | 270.01 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 82.94 Million TWD | 24.42% |
2024 Q2 | 54.6 Million TWD | -34.17% |
2023 Q2 | 61.47 Million TWD | -3.43% |
2023 Q4 | 66.66 Million TWD | -3.49% |
2023 Q3 | 69.07 Million TWD | 12.36% |
2023 FY | 260.85 Million TWD | 3.27% |
2023 Q1 | 63.65 Million TWD | -13.4% |
2022 Q4 | 73.5 Million TWD | 0.0% |
2022 FY | 252.6 Million TWD | 27.33% |
2021 FY | 198.38 Million TWD | -7.4% |
2020 FY | 214.24 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -202.432% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 99.221% |
Level Biotechnology Inc. | 151.99 Million TWD | 99.345% |
Sagittarius Life Science Corp | 135.85 Million TWD | 99.268% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 98.688% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.558% |
VBI | 32.55 Million TWD | 96.944% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 99.613% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 99.488% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 97.838% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.17% |
Visgeneer Inc. | 67.48 Million TWD | 98.526% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.265% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 99.805% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 98.443% |
Neith Corporation | 66.87 Million TWD | 98.512% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.931% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 96.61% |
Enimmune corporation | 220.1 Million TWD | 99.548% |
TaiRx, Inc. | 217.13 Million TWD | 99.542% |
CHO Pharma, Inc. | 268.99 Million TWD | 99.63% |
EirGenix Inc. | 236.74 Million TWD | 99.58% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 99.046% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 99.722% |
Lin BioScience, Inc. | 1.09 Billion TWD | 99.909% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 99.626% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 97.989% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | 8.126% |
Lukas Biomedical Inc. | 177.45 Million TWD | 99.439% |
RBC Bioscience Corporation | 58.35 Million TWD | 98.295% |
BiOptic Inc. | 108.69 Million TWD | 99.085% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -1005.556% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 98.565% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 61.95% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.845% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 98.934% |
NaviFUS Corp. | 11.82 Million TWD | 91.587% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 99.478% |
Sinew Pharma Inc. | 186.25 Million TWD | 99.466% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 98.656% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 99.549% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 97.601% |
AP Biosciences Inc | 32.25 Million TWD | 96.915% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.946% |
3D Global Biotech Inc. | 5.27 Million TWD | 81.134% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 99.686% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.607% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 99.912% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 97.601% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 99.413% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 99.323% |
TCI GENE Inc. | 174.61 Million TWD | 99.43% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -5427.778% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 99.669% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 99.658% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 98.815% |
PharmaEngine, Inc. | 441.78 Million TWD | 99.775% |
Savior Lifetec Corporation | 223.36 Million TWD | 99.555% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 99.616% |
OBI Pharma, Inc. | 2.01 Billion TWD | 99.951% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.284% |
Acepodia, Inc. | 452.56 Million TWD | 99.78% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 99.816% |